Merck Ltd renamed as Procter & Gamble Health Ltd

Image
Press Trust of India New Delhi
Last Updated : May 07 2019 | 2:15 PM IST

Drug firm Merck Ltd Tuesday said it has been renamed as Procter & Gamble Health Ltd following P&G's global acquisition of the consumer health business of Merck KGaA, Germany.

"The company has received approval from the Registrar of Companies, Mumbai, Maharashtra, for change of name from Merck Ltd to Procter & Gamble Health Ltd effective May 6, 2019," Merck said in a filing to the BSE.

The company is taking necessary steps to comply with the formalities and documentation, as may be required by the stock exchanges to record the said change in its records, it added.

Procter & Gamble Health Ltd Managing Director Milind Thatte said, "Our new name reflects our new identity as part of the P&G Group and signifies the coming together of strong consumer health capabilities and cultures".

Together, "we are working towards leveraging our combined expertise to develop categories and brands that meet today's needs and tomorrow's opportunities," he added.

The decision to change the name of the listed entity in India follows the successful completion of P&G's global acquisition of the consumer health business of Merck KGaA, Darmstadt, Germany, the filing said.

The consumer health business was transferred to P&G on December 1, 2018, it added.

"I am delighted to announce the new name of our listed entity which will now be known as Procter & Gamble Health Ltd," Procter & Gamble Global Personal Health Care President Tom Finn said.

With India's over-the-counter (OTC) market growing at double the global growth rate, "this is a exciting phase for all of us, as we now move forward to realise the great potential of our two health-related P&G businesses in India", he added.

Procter & Gamble Health Ltd will be a part of P&G's Personal Health Care International Business Unit led by Uta Kemmerich-Keil (vice-president, Personal Health Care International), the company said.

Shares of Merck Ltd were trading at Rs 3,689.20 per scrip on the BSE, up 2.08 per cent from its previous close.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 07 2019 | 2:15 PM IST

Next Story